“INFLAMMAGING” AND ITS MANAGEMENT IN PRESBYCUSIS
 
 
More details
Hide details
1
Institute of Sound and Vibration Research, Faculty of Engineering and the Environment, University of Southampton, U.K.
 
 
Publication date: 2012-12-31
 
 
Corresponding author
Carl Verschuur   

Carl Verschuur, Institute of Sound and Vibration Research, Faculty of Engineering and the Environment, University of Southampton, U.K., e-mail: cav@isvr.soton.ac.uk
 
 
J Hear Sci 2012;2(4):46-48
 
ABSTRACT
Background:
From human studies there is little published evidence on the biological basis for presbycusis. We report a previously published study which tested the hypothesis that chronic inflammation in the elderly, known as “inflammaging” is a causal factor for presbycusis.

Material and Methods:
Analysis of biological and audiological data from a large population cohort showed an independent association between a range of inflammatory markers and mean hearing level.

Discussion:
Our findings suggest that further investigation into the role of inflammation in causing presbycusis is warranted. We also discuss wider research plans, and argue for a greater understanding of the inter-relationship of systemic and cochlear inflammation and the role of inflammatory processes in causing a range of types of hearing loss.

 
REFERENCES (16)
1.
Larbi A, Franceschi C, Mazzatti D et al: Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda, Md.), 2008; 23: 64–74.
 
2.
Hunt KJ, Walsh BM, Voegeli D, Roberts HC: Inflammation in aging part 1: physiology and immunological mechanisms. Biol Res Nurs, 2010; 11(3): 245–52.
 
3.
Harris JP, Ryan F: Immunobiology of the inner ear. Am J Otolaryngol, 1984; 5(6): 418–25.
 
4.
Satoh H, Firestein GS, Billings PB et al: Proinflammatory Cytokine Expression in the Endolymphatic Sac During Inner Ear Inflammation. J Assoc Res Otolaryngol, 2003; 4(2): 139–47.
 
5.
Gates GA, Cobb JL, D’Agostino RB, Wolf PA: The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg, 1993; 119(2): 156–61.
 
6.
Lin FR, Metter EJ, O’Brien RJ et al: Hearing loss and incident dementia. Arch Neurol, 2011; 68(2): 214–20.
 
7.
Frisina ST, Mapes F, Kim S et al: Characterization of hearing loss in aged type II diabetics. Hear Res, 2006; 211(1–2): 103–13.
 
8.
8, Verschuur CA, Dowell A, Syddall HE et al: Markers of inflammatory status are associated with hearing threshold in older people: findings from the Hertfordshire Ageing Study. Age Ageing, 2012; 41(1): 92–97.
 
9.
Holmes C, Cunningham C, Zotova E et al: Systemic inflammation and disease progression in Alzheimer disease. Neurology, 2009; 73(10): 768–74.
 
10.
a Ashfield T, Syddall HE, Martin HJ et al: Grip strength andcardiovascular drug use in older people: findings from the Hertfordshire Cohort Study. Age Ageing, 2010; 39(2): 185–91.
 
11.
Robinson S, Syddall H, Jameson K et al: Current patterns of diet in community-dwelling older men and women: results from the Hertfordshire Cohort Study. Age Ageing, 2009; 38(5): 594–99.
 
12.
Ohlemiller KK: Mechanisms and genes in human strial presbycusis from animal models. Brain Res, 2009; 1277(314): 70–83.
 
13.
Haake SM, Dinh CT, Chen S et al: Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hear Res, 2009; 255(1–2): 22–32.
 
14.
Chang A, Eastwood H, Sly D et al: Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res, 2009; 255(1–2): 67–72.
 
15.
James DP, Eastwood H, Richardson RT, O’Leary SJ: Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation. Audiol Neurootol, 2008; 13(2): 86–96.
 
16.
Dinh CT, Van De Water TR: Blocking pro-cell-death signal pathways to conserve hearing. Audiol Neurootol, 2009; 14(6) 383–92.
 
Journals System - logo
Scroll to top